Marker Therapeutics, Inc. Common Stock Shares Outstanding

• Marker Therapeutics, Inc. showed an increase of +56.1% in Common Stock Shares Outstanding from 2024 to 2025.
• This data is from Marker Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 18, 2026.
• XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q2 2011: 46.81 million shares | Q1 2012: 54.33 million shares | Q3 2012: 73.86 million shares | Q4 2012: 76.40 million shares | Q1 2013: 76.40 million shares | Q3 2013: 144.31 million shares | Q2 2014: 16.81 million shares | Q3 2014: 19.60 million shares | Q1 2015: 32.64 million shares | Q2 2015: 38.04 million shares | Q3 2015: 62.89 million shares | Q1 2016: 70.99 million shares | Q2 2016: 71.42 million shares | Q3 2016: 8.40 million shares | Q1 2017: 8.47 million shares | Q2 2017: 10.16 million shares | Q3 2017: 10.50 million shares | Q1 2018: 10.60 million shares | Q2 2018: 13.60 million shares | Q3 2018: 13.80 million shares | Q1 2019: 45.50 million shares | Q2 2019: 45.50 million shares | Q3 2019: 45.70 million shares | Q1 2020: 46.50 million shares | Q2 2020: 46.60 million shares | Q3 2020: 48.00 million shares | Q1 2021: 83.00 million shares | Q2 2021: 83.10 million shares | Q3 2021: 83.10 million shares | Q1 2022: 83.50 million shares | Q2 2022: 83.60 million shares | Q3 2022: 83.60 million shares | Q1 2023: 8.80 million shares | Q2 2023: 8.80 million shares | Q3 2023: 8.80 million shares | Q1 2024: 8.90 million shares | Q2 2024: 8.90 million shares | Q3 2024: 8.90 million shares | Q1 2025: 11.20 million shares | Q2 2025: 11.30 million shares | Q3 2025: 16.70 million shares.
• Over the full 16 years of available data (2010 to 2025), Marker Therapeutics, Inc.'s Common Stock Shares Outstanding has declined by 58.5%.
• Historical annual values: Fiscal year 2025: 16.70 million shares | Fiscal year 2024: 10.70 million shares | Fiscal year 2023: 8.90 million shares | Fiscal year 2022: 8.40 million shares | Fiscal year 2021: 8.30 million shares | Fiscal year 2020: 50.70 million shares | Fiscal year 2019: 45.70 million shares | Fiscal year 2018: 45.40 million shares | Fiscal year 2017: 10.60 million shares | Fiscal year 2016: 8.40 million shares | Fiscal year 2015: 5.88 million shares | Fiscal year 2014: 20.32 million shares | Fiscal year 2013: 1.47 million shares | Fiscal year 2012: 76.40 million shares | Fiscal year 2011: 52.07 million shares | Fiscal year 2010: 40.26 million shares.
• Data sourced from SEC EDGAR public filings as of August 10, 2026.

Last verified: August 10, 2026